Skip to main content
. 2017 Mar 31;8(21):34811–34819. doi: 10.18632/oncotarget.16746

Table 4. Incidence density rates and hazard ratios for different subtypes of pathologic fracture in the HSCT group comparing with the non-HSCT group.

Subtypes of fracture (ICD-9-CM code) Non-HSCT group HSCT group HR (95% CI)
Event no. IR Event no. IR Crude Adjusteda(95% CI)
Pathologic fracture (733.1) 4 0.18 0 0.00 - -
Pathologic fracture, unspecified site (733.10) 4 0.18 1 0.26 1.43 (0.16–12.8) 1.72 (0.18–16.8)
Pathologic fracture of humerus (733.11) 4 0.18 2 0.51 2.83 (0.52–15.5) 3.42 (0.60–19.7)
Pathologic fracture of distal radius and ulna (733.12) 0 0.00 0 0.00 - -
Pathologic fracture of vertebrae (733.13) 30 1.34 13 3.34 2.43 (1.27–4.67)** 2.73 (1.40–5.33)**
Pathologic fracture of neck of femur (733.14) 4 0.18 1 0.26 1.35 (0.15–12.2) 1.86 (0.20–17.6)
Pathologic fracture of other specified part of femur (733.15) 2 0.09 0 0.00 - -
Pathologic fracture of tibia or fibula (733.16) 2 0.09 2 0.51 5.67 (0.79–40.5) 9.30 (0.97–89.4)
Pathologic fracture of other specified site (733.19) 4 0.18 0 0.00 - -

HSCT: hematopoietic stem cell transplant; IR: incidence density rate per 1000 person-years; HR: hazard ratio; CI: confidence interval.

aModel adjusting for sex, age, diabetes mellitus, hyperlipidemia, hypertension, coronary artery disease, depression, stroke, chronic obstructive pulmonary disease, chronic kidney disease, and the type of cancer.

**P < 0.01.